These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6322910)

  • 1. Ceftizoxime in the treatment of uncomplicated gonorrhoea.
    Spencer RC; Smith T; Talbot MD
    Br J Vener Dis; 1984 Apr; 60(2):90-1. PubMed ID: 6322910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftizoxime (FK-749) is effective therapy for urethritis caused by penicillinase-producing Neisseria gonorrhoeae.
    Harrison WO; Sanchez PL; Lancaster DJ; Kerbs SB; Berg SW
    Sex Transm Dis; 1984; 11(1):30-1. PubMed ID: 6324399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Neisseria gonorrhoeae to ceftizoxime in vitro and in vivo.
    Korting HC; Neubert U
    Chemotherapy; 1984; 30(5):322-7. PubMed ID: 6092006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ceftizoxime and penicillin for the treatment of uncomplicated gonorrhoea.
    Lutz B; Mogabgab WJ; Parks D; Pauling B; Beville R
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():229-35. PubMed ID: 6296012
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of aztreonam in the treatment of uncomplicated gonorrhoea.
    Spencer RC; Talbot MD
    Curr Med Res Opin; 1985; 9(9):591-3. PubMed ID: 2932303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftizoxime for treatment of gonorrhoea.
    Slutkin G; Gottlieb A; Mills J
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():237-9. PubMed ID: 6296013
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of cefotetan in uncomplicated gonorrhea.
    Korting HC; Abeck D; Neubert U
    Dermatologica; 1986; 173(5):237-44. PubMed ID: 3100355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of gonorrhoea with cefotiam: activity in vitro and clinical results of a 1-gram single-dose regimen.
    Korting HC; Neubert U
    Dermatologica; 1985; 171(4):264-8. PubMed ID: 3935494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Richards DM; Heel RC
    Drugs; 1985 Apr; 29(4):281-329. PubMed ID: 3888599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of ceftriaxone and spectinomycin in the treatment of uncomplicated gonorrhea in women.
    Collier AC; Judson FN; Murphy VL; Leach LA; Root CJ; Handsfield HH
    Am J Med; 1984 Oct; 77(4C):68-72. PubMed ID: 6093523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma, cantharides blister fluid, and suction blister fluid levels of ceftizoxime after single intramuscular application for gonorrhea.
    Korting HC; Schäfer-Korting M; Haag R; Mutschler E
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):218-20. PubMed ID: 6325353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of non-complicated urogenital, rectal and oropharyngeal gonorrhoea with intramuscular cefotaxime 1.0 g or cefuroxime 1.5 g.
    Stolz E; Ong L; van Joost T; Michel MF
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():295-9. PubMed ID: 6094455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparative study of 0.5 and 1 g of cefodizime (HR 221) versus 1 g of cefotaxime for acute uncomplicated urogenital gonorrhea.
    van der Willigen AH; Wagenvoort JH; Schalla WO; Knapp JS; Boot JM; Heeres-Weststrate PL; Michel MF; van Klingeren B; Stolz E
    Antimicrob Agents Chemother; 1988 Apr; 32(4):426-9. PubMed ID: 3377456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of Neisseria gonorrhoeae to cefotaxime: in vitro studies and treatment results.
    Neubert U; Korting HC; Ruckdeschel G
    Arch Dermatol Res; 1982; 274(3-4):321-6. PubMed ID: 6299208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single 1 g dose of cefotaxime in the treatment of infections due to penicillinase-producing strains of Neisseria gonorrhoeae.
    de Koning GA; Tio D; van den Hoek JA; van Klingeren B
    Br J Vener Dis; 1983 Apr; 59(2):100-2. PubMed ID: 6299449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bacteriological and clinical evaluation of ceftizoxime in male gonorrheal urethritis].
    Okazaki T
    Jpn J Antibiot; 1983 Dec; 36(12):3336-42. PubMed ID: 6325750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-shot treatment of uncomplicated gonorrhoea with third-generation cephalosporins with differing serum half-life. Results of a controlled trial with ceftriaxone and cefotaxime.
    Korting HC; Abeck D
    Chemotherapy; 1989; 35(6):441-8. PubMed ID: 2515041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of uncomplicated gonorrhea with cefotaxime.
    Handsfield HH
    Rev Infect Dis; 1982; 4 Suppl():S448-52. PubMed ID: 6294798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised comparative study of ceftriaxone and spectinomycin in gonorrhoea.
    Panikabutra K; Ariyarit C; Chitwarakorn A; Saensanoh C; Wongba C
    Genitourin Med; 1985 Apr; 61(2):106-8. PubMed ID: 3156805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefotaxime in the treatment of gonorrhoea caused by beta-lactamase-producing Neisseria gonorrhoeae.
    Barlow D; Phillips I
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():291-3. PubMed ID: 6094454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.